Table 2 Tail length (px), %DNA in tail and tail moment in the brain tissue of the negative control group and groups administered acrylamide or/and TiO2NPs.
Group | Treatment (dose mg/kg) | Tail length (px) | %DNA in tail | Tail moment |
|---|---|---|---|---|
I | Negative control (deionized water) | 3.93 ± 0.51a | 10.18 ± 1.23a | 0.42 ± 0.03a |
II | Acrylamide (3 mg/kg) | 7.12 ± 0.43b | 17.73 ± 1.68b | 1.27 ± 0.04b |
III | TiO2-NPs (5 mg/kg) | 9.09 ± 0.87c | 26.45 ± 3.32c | 2.42 ± 0.30c |
IV | Acrylamide + TiO2-NPs | 10.43 ± 1.70c | 35.12 ± 2.90d | 3.64 ± 0.31d |
One Way Analysis of Variance | F = 23.05 P < 0.001 | F = 57.74 P < 0.001 | F = 126.39 P < 0.001 | |